Release Date: 30/10/23 09:34 Summary: Quarterly Activities/Appendix 4C Cash Flow Report Price Sensitive: Yes Download Document 392.83KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status